A double blinded, placebo-controlled pilot study to examine reduction of CD34 (+)/CD117 (+)/CD133 (+) lymphoma progenitor cells and duration of remission induced by neoadjuvant val...

Por Ito, Daisuke, Childress, Michael, Mason, Nicola, Winter, Amber, O’Brien, Timothy, Henson, Michael, Borgatti, Antonella, Lewellen, Mitzi, Krick, Erika, Stewart, Jane, Lahrman, Sarah, Rajwa, Bartek, Scott, Milcah C, Seelig, Davis, Koopmeiners, Joseph, Ruetz, Stephan, Modiano, Jaime
Publicado no F1000Res (2017)

A distinct p53 target gene set predicts for response to the selective p53–HDM2 inhibitor NVP-CGM097

Por Jeay, Sébastien, Gaulis, Swann, Ferretti, Stéphane, Bitter, Hans, Ito, Moriko, Valat, Thérèse, Murakami, Masato, Ruetz, Stephan, Guthy, Daniel A, Rynn, Caroline, Jensen, Michael R, Wiesmann, Marion, Kallen, Joerg, Furet, Pascal, Gessier, François, Holzer, Philipp, Masuya, Keiichi, Würthner, Jens, Halilovic, Ensar, Hofmann, Francesco, Sellers, William R, Graus Porta, Diana
Publicado no eLife (2015)

Correction: A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097

Por Jeay, Sébastien, Gaulis, Swann, Ferretti, Stéphane, Bitter, Hans, Ito, Moriko, Valat, Thérèse, Murakami, Masato, Ruetz, Stephan, Guthy, Daniel A, Rynn, Caroline, Jensen, Michael R, Wiesmann, Marion, Kallen, Joerg, Furet, Pascal, Gessier, François, Holzer, Philipp, Masuya, Keiichi, Würthner, Jens, Halilovic, Ensar, Hofmann, Francesco, Sellers, William R, Graus Porta, Diana
Publicado no eLife (2016)